Carmel Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Carmel Capital Partners’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,535	Closed	-$239K	–	430
2023 Q3	$239K	Buy	1,535 +277	+22%	+$45.7K	0.11%	132
2023 Q2	$208K	Sell	1,258 -567	-31%	-$91.5K	0.11%	114
2023 Q1	$283K	Sell	1,825 -195	-10%	-$31.5K	0.17%	100
2022 Q4	$357K	Buy	2,020 +425	+27%	+$73.4K	0.25%	85
2022 Q3	$261K	Hold	1,595	–	–	0.25%	89
2022 Q2	$283K	Buy	1,595 +250	+19%	+$44.5K	0.26%	84
2022 Q1	$238K	Sell	1,345 -40	-3%	-$6.81K	0.2%	101
2021 Q4	$237K	Buy	+1,385	New	+$227K	0.18%	100

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Carmel Capital Partners's JNJ Position: Q4 2023 in Review

Carmel Capital Partners sold out of Johnson & Johnson (JNJ) in Q4 2023, closing a stake of 1,535 shares — an estimated $239K sold.

Carmel Capital Partners first reported a position in JNJ in Q4 2021 and held it in 8 quarters. The position peaked at $357K in Q4 2022. 3,869 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

Carmel Capital Partners reported no remaining Johnson & Johnson position as of Q4 2023 after selling out during the quarter.
Carmel Capital Partners sold 1,535 Johnson & Johnson shares in Q4 2023, an estimated $239K.
Carmel Capital Partners first reported a position in Johnson & Johnson in Q4 2021 and held it in 8 quarters.
Carmel Capital Partners's Johnson & Johnson position peaked at $357K in Q4 2022.
3,869 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Carmel Capital Partners's 13F filing for Q4 2023, filed 1 Feb 2024.